Skip to main content
. 2023 Jun 27;13:1153128. doi: 10.3389/fonc.2023.1153128

Figure 4.

Figure 4

Overall survival for both regimens. ICE, ifosfamide, carboplatin, and etoposide; G: gemcitabine and vinorelbine.